human pooled reference plasma sample (BioIVT Inc)
90
Structured Review
BioIVT Inc
human pooled reference plasma sample
Human Pooled Reference Plasma Sample, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+pool+plasma/human+plasma/pmc10730409__41380_2023_2180_MOESM1_ESM-114-7-11
Average 90 stars, based on 1 article reviews
Human Pooled Reference Plasma Sample, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+pool+plasma/human+plasma/pmc10730409__41380_2023_2180_MOESM1_ESM-114-7-11
Average 90 stars, based on 1 article reviews
human pooled reference plasma sample - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor Article Snippet: Mark Y. Chan1; Min Lin2; Joseph Lucas3; Arthur Moseley4; J.. Will Thompson4; Derek Cyr3; Hitoshi Ueda5; Mariko Kajikawa5; Thomas L. Ortel6; Richard C. Becker6,7 1National University Heart Centre, Singapore; 2Duke Translational Medicine Institute, Durham, North Carolina, USA; 3Center for Applied Genomics and Technology, Duke Institute for Genome Sciences & Policy, Durham, North Carolina, USA; 4Proteomics Core Facility, Duke Institute for Genome Sciences & Policy, Durham, North Carolina, USA; 5Bayer Yakuhin Ltd, Osaka, Japan; 6Duke University Medical Center Hemostasis & Thrombosis Center Core Laboratory, Durham, North Carolina, USA; 7Duke Clinical Research Institute, Durham, North Carolina, USA Control:Article Title: Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor Article Snippet: Mark Y. Chan1; Min Lin2; Joseph Lucas3; Arthur Moseley4; J.. Will Thompson4; Derek Cyr3; Hitoshi Ueda5; Mariko Kajikawa5; Thomas L. Ortel6; Richard C. Becker6,7 1National University Heart Centre, Singapore; 2Duke Translational Medicine Institute, Durham, North Carolina, USA; 3Center for Applied Genomics and Technology, Duke Institute for Genome Sciences & Policy, Durham, North Carolina, USA; 4Proteomics Core Facility, Duke Institute for Genome Sciences & Policy, Durham, North Carolina, USA; 5Bayer Yakuhin Ltd, Osaka, Japan; 6Duke University Medical Center Hemostasis & Thrombosis Center Core Laboratory, Durham, North Carolina, USA; 7Duke Clinical Research Institute, Durham, North Carolina, USA |